Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection, to make significant advancements in cancer diagnostics. Valued at nearly $1m, the ...

Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection, to make significant advancements in cancer diagnostics. Valued at nearly $1m, the ...

Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "DNA Extraction Kit Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The center of the ...

CRISPR-Cas9, the gene editing tool that is currently the darling of biotech and many other fields, may not be quite as miraculous as early tests suggested. A new study finds that what scientists ...

Osaka Metropolitan University scientists have developed a light-induced DNA detection technique, using heterogeneous probe particles, that enables ultra-sensitive and ultra-fast genetic analysis ...

(RTTNews) - Aditxt, Inc. (ADTX) Monday announced that its subsidiary, Pearsanta, Inc., has acquired patents related to adductomics-based DNA damage detection, strengthening its position in cancer ...

Background: A blood-based biomarker to predict the risk of hepatocellular carcinoma (HCC), and its recurrence is needed. Previously, we showed that γ-OHPdG, a mutagenic DNA adduct formed by lipid ...

Researchers at the University of Wisconsin-Madison have developed a machine-learning model to detect cancer in its early stages by looking at DNA fragments from cancer cells in the blood, they say.

If DNA damage is not properly repaired, mutations can occur, which may result in diseases like cancer. Cells use repair systems to fix this damage, with specialized proteins locating and binding ...